Literature DB >> 19705374

Extent of liver resection for hilar cholangiocarcinoma.

X-P Chen1, W Y Lau, Z-Y Huang, Z-W Zhang, Y-F Chen, W-G Zhang, F-Z Qiu.   

Abstract

BACKGROUND: The extent of liver resection for hilar cholangiocarcinoma (HC) remains controversial despite extensive studies. The aim of this study was to determine the safety and efficacy of minor and major hepatectomy, selected by predetermined criteria in patients with HC.
METHODS: From 2000 to 2007, 187 patients with HC were studied prospectively; 138 patients underwent resection with curative intent. Minor hepatectomy was performed in 93 patients with Bismuth-Corlette type I, II or III HC without hepatic arterial or portal venous invasion, and major hepatectomy in 45 patients with type III HC with hepatic arterial or portal venous invasion, or type IV HC.
RESULTS: Overall mortality and morbidity rates were 0 and 29.7 per cent respectively, and the bile leak rate was 1.4 per cent. Actuarial 1-, 3- and 5-year survival rates were 87, 54 and 34 per cent respectively in the minor liver resection group, and 80, 42 and 27 per cent for major resection (P = 0.300).
CONCLUSION: Minor liver resection for HC, selected by predetermined criteria, had good results. Major liver resection, which had a higher operative morbidity rate than minor resection, should be reserved for Bismuth-Corlette type III HC with vascular invasion, or type IV HC.

Entities:  

Mesh:

Year:  2009        PMID: 19705374     DOI: 10.1002/bjs.6618

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

1.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 2.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

Review 3.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

4.  Treatment of complicated hepatic cystic hydatidosis with intrabiliary rupture by pericystectomy in combination with Roux-en-Y hepaticojejunostomy.

Authors:  Hongqiang Yang; Jingxia Tang; Xinyu Peng; Shijie Zhang; Hong Sun; Hailong Lv; Jiang Li; Xiaoping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

5.  Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group.

Authors:  Jean Marc Regimbeau; David Fuks; Yves-Patrice Le Treut; Philippe Bachellier; Jacques Belghiti; Karim Boudjema; Jacques Baulieux; François-René Pruvot; Daniel Cherqui; Olivier Farges
Journal:  J Gastrointest Surg       Date:  2011-01-20       Impact factor: 3.452

6.  Minimally invasive approaches to extrapancreatic cholangiocarcinoma.

Authors:  Andrew A Gumbs; Nicolas Jarufe; Brice Gayet
Journal:  Surg Endosc       Date:  2012-08-28       Impact factor: 4.584

7.  Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.

Authors:  Bas Groot Koerkamp; Jimme K Wiggers; Peter J Allen; Marc G Besselink; Leslie H Blumgart; Olivier R C Busch; Robert J Coelen; Michael I D'Angelica; Ronald P DeMatteo; Dirk J Gouma; T Peter Kingham; William R Jarnagin; Thomas M van Gulik
Journal:  J Am Coll Surg       Date:  2015-09-15       Impact factor: 6.113

Review 8.  An update on liver surgery for cholangiocarcinoma.

Authors:  Karim Boudjema; Giovanni Battista Levi Sandri; Eveline Boucher; Tanguy Rohou; Michel Rayar; Laurent Sulpice
Journal:  Updates Surg       Date:  2013-10-02

9.  Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients.

Authors:  Li Jingdong; Xiong Yongfu; Gang Yang; Xu Jian; Huang Xujian; Liu Jianhua; Zhao Wenxing; Qin Renyi; Yin Xinming; Zheng Shuguo; Liang Xiao; Peng Bin; Zhang Qifan; Li Dewei; Tang Zhao-Hui
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

10.  Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.

Authors:  Xinsen Xu; Linhua Yang; Wei Chen; Min He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.